Full history for every metric is available with a Kvantra account
Delta 9 Cannabis Inc. (DN.TO)
Key financial summary
Financials in CAD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | CAD m | 8 | 32 | 52 | 62 | 63 | 71 | 71 |
| Operating profit | CAD m | -22 | -18 | |||||
| Net profit | CAD m | -8 | 14 | -6 | -11 | -27 | -18 | -20 |
| EPS reported | CAD | -0.10 | -0.10 | |||||
| Operating cashflow per share | CAD | 0.02 | 0.02 | |||||
| Capex per share | CAD | 0.00 | 0.00 | |||||
| FCF per share | CAD | 0.01 | 0.01 | |||||
| Free cash flow | CAD m | 3 | 4 | |||||
| Net debt | CAD m | 62 | 45 | |||||
| Book value equity | CAD m | -7 | -10 | |||||
| Book value per share | CAD | -0.04 | -0.04 | |||||
| Number of shares | m | 178.94 | 229.26 | |||||
| DPS (TTM paid) | CAD | 0.00 | 0.00 |
Financial summary
Financials in CAD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -0.61 | -0.15 | |||||
| P/S LTM | x | 0.06 | 0.02 | |||||
| P/FCF LTM | x | 1.74 | 0.42 | |||||
| EV/EBITDA LTM | x | -55.17 | -13.46 | |||||
| EV/Sales LTM | x | 0.94 | 0.66 | |||||
| Earnings Yield LTM | % | -391.52% | -1957.6% | |||||
| FCF Yield | % | 57.45% | 238.87% | |||||
| Quality | ||||||||
| ROE | % | 240.59% | 4898.7% | |||||
| ROIC | % | -36.66% | -36.66% | |||||
| Operating margin | % | -30.57% | -30.57% | |||||
| Gross margin | % | -3.38% | -3.38% | |||||
| FCF/Sales | % | 3.62% | 3.62% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +12.39% | +4.44% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.04 | 0.06 | |||||
| Net Debt/EBITDA | x | -51.48 | -51.48 | |||||
| EBIT/Net interest | x | -3.19 | -3.19 | |||||
| Net debt/market cap | % | 1396.0% | 2991.5% | |||||
| Net debt/Equity | x | -8.58 | -4.47 | |||||
| Gross debt/equity | x | -8.87 | -6.39 | |||||
Company overview
Delta 9 Cannabis Inc. is a diversified enterprise operating across various segments of the cannabis industry. Its subsidiary, Delta 9 Bio-Tech Inc., handles the cultivation, processing, extraction, and distribution of both medicinal and recreational cannabis products, managing both wholesale and retail channels. The product portfolio spans dried cannabis flower, pre-rolled joints, dried sift, various oils, and a range of extracted and derivative offerings; notably, they also provide decontamination pods. Furthermore, Delta 9 supplies grow pods and live cannabis plants to other businesses, including those already licensed and those awaiting licensure. Beyond product sales, the company runs a medical clinic where physicians offer consultations to patients looking for a medical recommendation for cannabis prescriptions. As of April 20, 2022, Delta 9 operated a network of 35 branded retail outlets throughout the Canadian Prairies. Established in 2001, its corporate headquarters are located in Winnipeg, Canada.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Delta 9 Cannabis Inc. (DN.TO)
Delta 9 Cannabis Inc. is a diversified enterprise operating across various segments of the cannabis industry. Its subsidiary, Delta 9 Bio-Tech Inc., handles the cultivation, processing, extraction, and distribution of both medicinal and recreational cannabis products, managing both wholesale and retail channels. The product portfolio spans dried cannabis flower, pre-rolled joints, dried sift, various oils, and a range of extracted and derivative offerings; notably, they also provide decontamination pods. Furthermore, Delta 9 supplies grow pods and live cannabis plants to other businesses, including those already licensed and those awaiting licensure. Beyond product sales, the company runs a medical clinic where physicians offer consultations to patients looking for a medical recommendation for cannabis prescriptions. As of April 20, 2022, Delta 9 operated a network of 35 branded retail outlets throughout the Canadian Prairies. Established in 2001, its corporate headquarters are located in Winnipeg, Canada.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free